Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedA 403 Forbidden error page is now shown at the study URL, replacing the expected study content with a generic error screen and the site header/footer. This reflects an access/server error rather than a substantive update to the page's information.SummaryDifference19%

- Check13 days agoChange DetectedThe page now includes 'Ovarian cancer' in the related topics and adds a MedlinePlus Genetics related topics entry. These changes broaden educational cross-links and navigation for readers without altering the study details.SummaryDifference0.1%

- Check20 days agoChange DetectedThe ovarian cancer condition label and the related topics section have been removed from the study page. The MedlinePlus Genetics tag is no longer displayed.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page's metadata now shows ovarian cancer as a related topic and links to MedlinePlus Genetics, and the site revision has been updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check34 days agoChange DetectedAn NIH funding attribution line '2016 ( U.S. NIH Grant/Contract )' was added to the study listing. Related-topic tags 'Ovarian cancer' and 'MedlinePlus Genetics' were removed from the MedlinePlus related topics.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, signaling a newer version of the page. This update is metadata-related and does not modify the study details or content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.